프리필드 시린지 시장 예측 : 유형별, 재질별, 설계별, 유통 채널별, 용도별 및 지역별 분석(-2034년)

According to Stratistics MRC, the Global Prefilled Syringes Market is accounted for $11.7 billion in 2026 and is expected to reach $30.8 billion by 2034 growing at a CAGR of 12.9% during the forecast period. Prefilled syringes are ready-to-use medical devices containing a premeasured dose of medication, sealed and sterilized for single-use injection. Comprising a barrel, plunger and needle, they offer convenience, accuracy, and safety in drug administration. Prefilled syringes reduce dosing errors, contamination risks and streamline medical procedures, catering to diverse healthcare needs across various treatments, from vaccines and biologics to chronic disease management and emergency medicine.

According to a report published by Geneva Association, in the last two decades, the share of total aggregate global expenditure on healthcare in GDP has increased from about 8% to almost 10%, or an estimated USD 8 trillion per annum.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The escalating incidence of chronic illnesses, such as diabetes, autoimmune disorders, and various neurological conditions, has propelled the prefilled syringes market. These conditions require regular and precise medication dosages, fostering the demand for user-friendly, accurate drug delivery systems like prefilled syringes. Offering convenience, dosage accuracy and reduced risks of contamination or dosage errors, prefilled syringes address the needs of patients requiring frequent medication. Additionally, this rising prevalence of chronic diseases emphasizes the market's growth trajectory as healthcare providers increasingly opt for efficient, ready-to-administer solutions to enhance patient care and management of these conditions.

Restraint:

Injection volume limitations

These syringes offer convenience and accurate dosing for many medications, they often come with fixed or limited injection volumes. This constraint affects certain drugs requiring larger doses or those with variable dosage needs. For medications that exceed the syringe's volume capacity, alternative delivery systems must be considered, limiting the universal applicability of prefilled syringes across all medication types. This limitation in accommodating diverse dosage requirements restrains their widespread adoption in certain therapeutic areas, impacting their market penetration.

Opportunity:

Growing healthcare infrastructure across emerging markets

The expanding healthcare infrastructure in emerging markets presents a significant opportunity for the prefilled syringes market. As these regions witness substantial growth in medical facilities, there's a heightened demand for efficient and cost-effective drug delivery systems. Additionally, their potential for streamlined administration and storage in resource-limited settings enhances their attractiveness, driving their adoption and market expansion within burgeoning healthcare infrastructures across emerging economies.

Threat:

Stringent regulatory requirements and approval processes

Stringent regulatory requirements and approval processes pose a significant threat to the prefilled syringes market. The need to adhere to complex regulatory standards, especially regarding material compatibility, manufacturing standards and sterility assurance, prolongs the time and resources required for product development and market entry. Compliance challenges may lead to delays in approvals, increasing development costs and potentially limiting innovation. These rigorous regulations create barriers for new entrants, impacting market competitiveness and hindering market growth.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the prefilled syringes market. The urgent need for vaccination campaigns worldwide propelled demand for prefilled syringes to administer vaccines efficiently. Manufacturers faced increased production to meet global vaccine distribution requirements, leading to supply chain challenges and heightened competition for materials. Additionally, stringent safety measures, regulatory adaptations and the focus on mass vaccination campaigns accelerated innovation and investment in prefilled syringe technologies to ensure safe, efficient and scalable vaccine delivery solutions.

The glass segment is expected to be the largest during the forecast period

The glass segment is anticipated to secure the largest market share in prefilled syringes. Glass offers superior qualities such as chemical inertness, ensuring stability and compatibility with a wide range of medications. Its transparency enables easy visual inspection, which is crucial for drug integrity. With an increasing demand for biologics and sensitive formulations, glass's barrier properties against moisture and gases are preferred. Moreover, heightened concerns about drug interaction and the need for precise drug delivery amplify the preference for glass, solidifying its dominance in the prefilled syringes market.

The online stores segment is expected to have the highest CAGR during the forecast period

The online store segment is expected to witness the highest growth rate in the prefilled syringes market due to the increasing trend of e-commerce in healthcare. Online platforms provide convenience, accessibility, and a wide product range for consumers. With the rising adoption of digital platforms, patients and healthcare providers prefer the ease of ordering medical supplies online. The ongoing global shift towards digitalization and emphasizing contactless transactions further drives the anticipated rapid growth of online stores in the prefilled syringes market.

Region with largest share:

North America is poised to secure the largest market share in prefilled syringes due to a robust healthcare infrastructure, high awareness of advanced medical technologies, and a surge in demand for injectable drugs. The region's well-established pharmaceutical industry, coupled with significant investments in research and development, positions it as a key market for prefilled syringes. Additionally, increased focus on patient-centric drug delivery further fuels the adoption of prefilled syringes, contributing to North America's dominant position in the market.

Region with highest CAGR:

Asia Pacific's robust growth in the prefilled syringes market is attributed to the region's expanding healthcare infrastructure, rising investments in pharmaceuticals and a growing emphasis on patient safety. Increasing healthcare expenditure, a large patient population and government initiatives promoting advanced healthcare technologies drive the demand for prefilled syringes. Moreover, the region's escalating vaccination programs, coupled with the burgeoning prevalence of chronic diseases, bolster the adoption of prefilled syringes.

Key players in the market

Some of the key players in prefilled syringes market include BD (Becton, Dickinson and Company), Catalent, Daikyo Seiko, Ltd., Gerresheimer, Haselmeier GmbH, Nemera, Nipro Corporation, Recipharm, SCHOTT AG, SHL Group, Stevanato Group, Terumo Corporation, Vaccinex, Inc., Vetter Pharma International GmbH, Weigao Group, West Pharmaceutical Services, Inc., Wuxi AppTec and Ypsomed.

Key Developments:

In July 2023, KORU Medical Systems announced the 510(K) Submission for Freedom60(R) Infusion System with Hizentra(R) 50 mL Prefilled Syringes.

In May 2023, Nexus Pharmaceuticals announced the FDA approval of single-dose prefilled syringes for Emerphed(R) (ephedrine sulfate injection) used for the treatment of clinically important hypotension occurring in the setting of anesthesia.

In January 2022, Owen Mumford announced that it received approval for its UniSafe 1mL safety device for pre-filled syringes in Asia. In Europe, regulatory approval has also been granted for UniSafe 1mL, and the product is now available on the market as a combination product with a drug for the treatment of rheumatoid arthritis.

Types Covered:

• Disposable Prefilled Syringes
• Reusable Prefilled Syringes

Materials Covered:

• Glass
• Plastic

Designs Covered:

• Single-Chamber Prefilled Syringes
• Dual-Chamber Prefilled Syringes
• Customized Prefilled Syringes

Distribution Channels Covered:

• Retail Pharmacies and Drug Stores
• Ambulatory Surgery Centers
• Online Stores

Applications Covered:

• Anaphylaxis
• Diabetes
• Oncology
• Rheumatoid Arthritis
• Thrombosis
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 End User Analysis
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Prefilled Syringes Market, By Type

• 5.1 Introduction
• 5.2 Disposable Prefilled Syringes
• 5.3 Reusable Prefilled Syringes

6 Global Prefilled Syringes Market, By Material

• 6.1 Introduction
• 6.2 Glass
• 6.3 Plastic

7 Global Prefilled Syringes Market, By Design

• 7.1 Introduction
• 7.2 Single-Chamber Prefilled Syringes
• 7.3 Dual-Chamber Prefilled Syringes
• 7.4 Customized Prefilled Syringes

8 Global Prefilled Syringes Market, By Distribution Channel

• 8.1 Introduction
• 8.2 Retail Pharmacies and Drug Stores
• 8.3 Ambulatory Surgery Centers
• 8.4 Online Stores

9 Global Prefilled Syringes Market, By Application

• 9.1 Introduction
• 9.2 Anaphylaxis
• 9.3 Diabetes
• 9.4 Oncology
• 9.5 Rheumatoid Arthritis
• 9.6 Thrombosis
• 9.7 Other Applications

10 Global Prefilled Syringes Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 BD (Becton, Dickinson and Company)
• 12.2 Catalent
• 12.3 Daikyo Seiko, Ltd.
• 12.4 Gerresheimer
• 12.5 Haselmeier GmbH
• 12.6 Nemera
• 12.7 Nipro Corporation
• 12.8 Recipharm
• 12.9 SCHOTT AG
• 12.10 SHL Group
• 12.11 Stevanato Group
• 12.12 Terumo Corporation
• 12.13 Vaccinex, Inc.
• 12.14 Vetter Pharma International GmbH
• 12.15 Weigao Group
• 12.16 West Pharmaceutical Services, Inc.
• 12.17 Wuxi AppTec
• 12.18 Ypsomed